Abdominal vasculature in dynamic contrast-enhanced liver MRI at 3.0 T: an intraindividual comparative study using gadoxetate disodium and gadofosveset trisodium
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 33 (10) , 1258-1266
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Primovist, Eovist: What to expect?Journal of Hepatology, 2012
- Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPAJapanese Journal of Radiology, 2011
- Optimized high‐resolution contrast‐enhanced hepatobiliary imaging at 3 tesla: A cross‐over comparison of gadobenate dimeglumine and gadoxetic acidJournal of Magnetic Resonance Imaging, 2011
- Double-Dose Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients With Chronic Liver DiseaseInvestigative Radiology, 2011
- Normal Dynamic MRI Enhancement Patterns of the Upper Abdominal Organs: Gadoxetic Acid Compared With GadobutrolAmerican Journal of Roentgenology, 2009
- Vascular Enhancement in Early Dynamic Liver MR Imaging in an Animal Model: Comparison of Two Injection Regimen and Two Different Doses Gd-EOB-DTPA (Gadoxetic Acid) With Standard Gd-DTPAInvestigative Radiology, 2009
- Dynamic contrast‐enhanced magnetic resonance imaging of abdominal solid organ and major vessel: Comparison of enhancement effect between Gd‐EOB‐DTPA and Gd‐DTPAJournal of Magnetic Resonance Imaging, 2009
- Major achievements in hepatocellular carcinomaThe Lancet, 2009
- Dynamic and delayed contrast enhancement in upper abdominal MRI studies: Comparison of gadoxetic acid and gadobutrolEuropean Journal of Radiology, 2007
- Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.Radiology, 1995